Quince Appointed to Announce Medichecks’ Acquisition of Leger Clinic

Quince Creative Communications has been appointed to handle the PR for Medichecks’ acquisition of Leger Treatments, a leading provider of testosterone replacement therapy (TRT). This strategic move marks a significant milestone in making high-quality TRT more accessible and affordable for men across the UK.

The announcement is being rolled out across finance, business, regional and trade media to highlight how the acquisition aligns with Medichecks’ mission to break down barriers to diagnosis and treatment for testosterone deficiency.

Quince will leverage its expertise in healthcare, business, and finance PR to drive awareness of this transformative acquisition.

Charlotte Dovey, Founder of Quince Creative Communications, commented:

“We are thrilled to be working with Medichecks on this important milestone. This acquisition has the potential to change lives by improving access to testosterone treatment, and we’re proud to help communicate its significance to the wider industry. Our focus is on ensuring the right stakeholders - from investors to healthcare professionals - recognise the value of this move.”

With testosterone deficiency often overlooked, Medichecks’ integration of Leger will streamline access to testing and treatment, ensuring men receive the care they need without unnecessary hurdles. The move allows for seamless monitoring, simplifying processes and reducing costs for patients.

Alex Wortley, Marketing Lead at Medichecks, added:

“At Medichecks, we believe in making healthcare simple and accessible. Our acquisition of Leger reinforces this mission, and we’re excited to work with Quince to share our story with the right audiences.”

“By bringing Leger into the Medichecks family, we are ensuring that men across the UK have better access to life-changing testosterone treatment with expert-led care and a seamless testing and monitoring experience. This partnership allows us to innovate further, break down misconceptions about testosterone deficiency, and offer an even higher standard of care to those who need it most.”